Russell Investments Group, Ltd. Inhibrx, Inc. Transaction History

Russell Investments Group, Ltd.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$32.76 - $39.56 $8.03 Million - $9.69 Million	-245,061 Reduced 56.28%	190,389 $6.66 Million
Q4 2023 Feb 05, 2024	SELL	$14.5 - $38.0 $342,287 - $897,028	-23,606 Reduced 5.14%	435,450 $16.5 Million
Q3 2023 Nov 13, 2023	BUY	$15.75 - $26.31 $527,861 - $881,779	33,515 Added 7.88%	459,056 $8.42 Million
Q2 2023 Aug 10, 2023	BUY	$16.96 - $27.82 $1.82 Million - $2.98 Million	107,036 Added 33.61%	425,541 $11 Million
Q1 2023 May 09, 2023	SELL	$18.45 - $27.14 $19,188 - $28,225	-1,040 Reduced 0.33%	318,505 $6.01 Million
Q4 2022 Feb 08, 2023	SELL	$20.18 - $33.33 $424,970 - $701,896	-21,059 Reduced 6.18%	319,545 $7.87 Million
Q3 2022 Nov 04, 2022	BUY	$11.58 - $24.73 $1 Million - $2.14 Million	86,492 Added 34.04%	340,604 $6.11 Million
Q2 2022 Jul 29, 2022	BUY	$8.52 - $25.26 $761,151 - $2.26 Million	89,337 Added 54.22%	254,112 $2.88 Million
Q1 2022 May 05, 2022	SELL	$19.89 - $43.18 $1.87 Million - $4.05 Million	-93,806 Reduced 36.28%	164,775 $3.67 Million
Q4 2021 Jan 21, 2022	BUY	$26.75 - $46.02 $659,762 - $1.14 Million	24,664 Added 10.54%	258,581 $11.3 Million
Q3 2021 Nov 08, 2021	BUY	$25.18 - $37.81 $2.98 Million - $4.48 Million	118,467 Added 102.61%	233,917 $7.79 Million
Q2 2021 Aug 04, 2021	BUY	$14.69 - $27.52 $1.7 Million - $3.18 Million	115,450 New	115,450 $3.18 Million

18.6K

Ticker INBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,057,700
Market Cap $570M
Description
Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.